Bayer Should Ax Calcium Supplement Claims: Ad Regulator

Law360, New York (July 12, 2012, 6:46 PM ET) -- The National Advertising Division recommended Wednesday that Bayer HealthCare AG stop claiming or implying that one dose of its daily calcium supplement provides the same level of calcium as competing products that require two daily doses, saying the claim misleads consumers.

NAD said in a statement that Bayer and its advertisers did not use sufficient or reliable evidence — in particular, the division questioned the use of a pharmacokinetic study — to support its claims when advertising or marketing its Citracal Slow Release 1200.

Launched last...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required